Taysha Gene Therapies, Inc. (TSHA)
5.25
-0.25
(-4.55%)
USD |
NASDAQ |
Jan 02, 15:30
Taysha Gene Therapies EPS Diluted (Quarterly): -0.0926 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AngioDynamics, Inc. | -0.2648 |
| Anavex Life Sciences Corp. | -0.1144 |
| Bolt Biotherapeutics, Inc. | -3.722 |
| Neurogene, Inc. | -0.9898 |
| Aspire Biopharma Holdings, Inc. | -0.0374 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.73M |
| Total Expenses (Quarterly) | 32.73M |
| Enterprise Value | 1.278B |
| Earnings Yield | -6.75% |
| Normalized Earnings Yield | -6.503 |